If you sell cosmetics in Canada, or you’re planning to, this is the moment to pay attention. Health Canada has spent the past couple of years revising parts of the Cosmetic Regulations, and several of those changes are now taking effect. Fragrance allergens that used to hide under a single word on your label now need to be named. Ingredient concentration ranges have grown more detailed. And the line between a cosmetic and a natural health product matters more than ever for how your product gets classified.
Some brands will handle these updates smoothly. Others will get caught off guard, which usually leads to delays or rejected notifications. Let’s walk through what’s actually changing.
Why Canada’s Cosmetics Rules Are Changing
Canada regulates cosmetics differently than drugs or natural health products. There’s no pre-market approval here. Instead, the system relies on notification, ingredient restrictions, and after-the-fact enforcement. That approach has worked reasonably well, but it hasn’t kept pace with what’s happening internationally. The European Union has required detailed fragrance allergen disclosure for years, giving consumers a clear view of what’s in a product before they buy it. Canadian shoppers haven’t had the same transparency, and regulators have decided it’s time to close the gap.
The result is amendment SOR/2024-63, published in the Canada Gazette in April 2024, and it’s the biggest driver behind the Canada cosmetics regulation changes brands are dealing with in 2026.
The Biggest Shift Yet of Fragrance Allergen Disclosure
For years, companies could simply write “parfum” or “fragrance” on a label and move on. That’s no longer good enough. Health Canada is rolling out mandatory allergen disclosure in two phases, both with real deadlines.
Phase One: April 2026
Starting April 12, 2026, every cosmetic sold in Canada, new or already on the market, must disclose 24 specific fragrance allergens whenever they appear above a set threshold: 0.01% for rinse-off products and 0.001% for leave-on products.
Phase Two: August 2026
As of August 1, 2026, the requirement expands to newly introduced products. The allergen list expands from 24 to 81, aligning with the European Union’s expanded list under Regulation 1223/2009. Products already on the market get a transition window running until August 2028, but new launches don’t get that grace period.
What This Means for Your Ingredient List
This is where the new cosmetic ingredient rules in Canada get personal for formulators. Every fragrance supplier relationship needs a fresh look, with documentation confirming which allergens are in your blend and at what concentrations. Suppliers who can’t provide that information put your entire notification at risk.
Health Cosmetic Notification Requirements
None of the allergen changes matter if you’re not filing correctly. The Cosmetic Notification Form, or CNF, remains the backbone of Canadian cosmetics compliance.
The 10-Day Rule
As set out in Section 30 of the Cosmetic Regulations, manufacturers and importers are required to notify Health Canada within 10 days of a cosmetic being first sold in Canada. This isn’t an approval process; the CNF simply puts your product on record so regulators can respond quickly if a safety concern arises.
What Goes Into a CNF
A complete notification includes the product name and brand, the notifier’s identity and Canadian address, manufacturing and import details, the product’s function, if it’s leave-on or rinse-off, and a full ingredient declaration. Foreign brands without a Canadian office need a responsible person, typically an importer or distributor, to handle communications with Health Canada.
Updating Your Notification When Things Change
Filing once isn’t the end of the job. Section 31 requires a revised notification within 10 days whenever a material change occurs, such as a reformulation, a new address, or a discontinuation. Miss that window and the product can’t legally be sold until the correction is filed.
Filing the first time correctly keeps you off Health Canada’s radar. Canadian Natural Health Product Registry prepares and submits a compliant cosmetic notification form in Canada that brands can count on, with the accuracy and timing Health Canada expects. Contact us to get your notification filed correctly from day one!
Concentration Ranges Now Offer More Precision
Health Canada also tightened the requirements for declaring ingredient concentrations. Companies used to report concentrations using seven broad ranges. That system has now expanded to thirteen ranges, giving regulators a more accurate picture of what’s in a formula. If your documentation still uses the old seven-tier system, update it now rather than scrambling later.
Cosmetic vs Natural Health Product Classification Canada
Here’s a mistake that trips up more brands than you’d expect. The line between a cosmetic and a natural health product in Canada isn’t always obvious, and getting it wrong can shut down a launch entirely.
What Makes a Product a Cosmetic
Under the Food and Drugs Act, a cosmetic is any substance used for cleansing, improving, or altering the complexion, skin, hair, or teeth. Think moisturizers, shampoos, makeup, and deodorants. These products are notified, not licensed.
What Pushes a Product Into NHP Territory
The moment your packaging claims a product treats a condition, heals something, or delivers a medicinal effect, you’ve likely crossed into drug or natural health product territory. That triggers a more rigorous licensing process requiring evidence of safety and efficacy, not a simple notification.
Why Getting This Wrong Is Costly
Say you launch an anti-acne serum that promises to “clear acne.” Health Canada may classify that as a natural health product rather than a cosmetic, and that reclassification can pull your product from shelves and send you back to square one. Reviewing every word on your packaging before launch is the difference between a smooth market entry and a costly do-over.
The Cosmetic Ingredient Hotlist Keeps Evolving
The Cosmetic Ingredient Hotlist is Health Canada’s list of restricted or prohibited substances, and it isn’t static. Updates are informed by peer-reviewed research, international regulatory decisions, and environmental assessments.
A 2026 update proposal is already circulating, with new conditions affecting hair dyes, rinse-off hair products, nail products, and bath products. Brands that treat the Hotlist as a one-time checklist are often caught off guard when it’s revised.
How to Stay Compliant with Canadian Cosmetics Law
Staying ahead andcompliant with Canadian cosmetics law comes down to four habits:
- Audit your ingredient list regularly against both the Hotlist and the new allergen thresholds
- Assign a responsible person with a Canadian address who can respond to Health Canada without delay
- Keep your label and your CNF perfectly in sync, since a formulation change without a matching update creates a compliance gap
- Check Health Canada’s regulatory updates on a schedule instead of waiting for a deadline to force your hand
A Quick Look at the Timeline
What This Means for Cosmetics Regulations in 2026
Put it all together, and the direction is clear. Canada is steadily moving toward the ingredient transparency European regulators have required for years, and brands that treat compliance as an ongoing responsibility rather than a one-time task will have a much easier time of it.
The companies that get ahead of allergen disclosure, keep their classification correct, and stay current with the Hotlist won’t be scrambling when the next deadline arrives.
Frequently Asked Questions
When does Canada’s new fragrance allergen disclosure rule take effect?
The first phase begins on April 12, 2026, and requires disclosure of 24 fragrance allergens that exceed set thresholds. A second phase on August 1, 2026, expands that to 81 allergens for newly introduced products.
Do existing cosmetic products need to comply immediately?
No, products already on the Canadian market have a transition period running until August 2028 to meet the expanded allergen disclosure requirements.
What is the deadline for filing a Cosmetic Notification Form?
Manufacturers and importers must file within 10 days of first selling a cosmetic in Canada. The same 10-day window applies to any updates or discontinuations.
How do I know if my product is a cosmetic or a natural health product?
It comes down to your claims. A product that cleanses or improves appearance is typically a cosmetic. A product that claims to treat, heal, or prevent a condition is usually classified as a natural health product or a drug, each of which requires separate licensing.
Does Health Canada pre-approve cosmetics before they go on sale?
No, the Cosmetic Notification Form is a post-market notification, not an approval. Health Canada monitors products after they’re on the market and can take enforcement action if a product fails to meet safety or labeling requirements.
Conclusion
Regulatory change can feel overwhelming, especially with deadlines stacking up heading into 2026. But none of this is impossible to manage. It just requires attention, good documentation, and a willingness to review your formulas and labels before Health Canada does it for you. Brands that build compliance into their processes now will spend much less time firefighting later.
Navigating these updates doesn’t have to be done alone. Canadian Natural Health Product Registry helps Canadian and international brands secure a natural health product license in Canada, along with full cosmetic notification and label compliance support. Contact us today and keep your products market-ready no matter how the regulations shift!
Linda Beach is the founder, sole owner, and Director of Canadian Natural Health Product Registry (CNHPR), operating under Medical Botany Research. Based on Canada’s west coast, Linda has been providing regulatory consulting and compliance expertise to Canadian and international companies since 2004, when Canada’s Natural Health Products Regulations first came into effect.
A Certified Herbalist with a degree in Botany and Medical Research, Linda also holds certifications in several natural and complementary healing modalities. This combination of scientific training and hands-on herbal expertise gives her a unique perspective on the products she helps bring to market — from vitamins and herbal remedies to nutraceuticals, cosmeceuticals, and sports supplements.
Over her two decades working directly with Health Canada, Linda has built strong working relationships with regulators that have translated into consistent success in securing Natural Product Numbers (NPNs) for her clients. Her advocacy work has had industry-wide impact — including playing a key role in Health Canada’s decision to reinstate hempseed oil to its approved ingredient database after it had been removed, restoring a path to market for products containing the ingredient.
Through CNHPR, Linda guides clients through every stage of the licensing process: developing a tailored regulatory strategy, compiling required documentation, and managing submissions from signing through to Health Canada approval.
Linda Beach is the founder, sole owner, and Director of Canadian Natural Health Product Registry (CNHPR), operating under Medical Botany Research. Based on Canada’s west coast, Linda has been providing regulatory consulting and compliance expertise to Canadian and international companies since 2004, when Canada’s Natural Health Products Regulations first came into effect.
A Certified Herbalist with a degree in Botany and Medical Research, Linda also holds certifications in several natural and complementary healing modalities. This combination of scientific training and hands-on herbal expertise gives her a unique perspective on the products she helps bring to market — from vitamins and herbal remedies to nutraceuticals, cosmeceuticals, and sports supplements.
Over her two decades working directly with Health Canada, Linda has built strong working relationships with regulators that have translated into consistent success in securing Natural Product Numbers (NPNs) for her clients. Her advocacy work has had industry-wide impact — including playing a key role in Health Canada’s decision to reinstate hempseed oil to its approved ingredient database after it had been removed, restoring a path to market for products containing the ingredient.
Through CNHPR, Linda guides clients through every stage of the licensing process: developing a tailored regulatory strategy, compiling required documentation, and managing submissions from signing through to Health Canada approval.